Health news and discussion on TalkFuse.
New prostate cancer screening guidelines mean changes for men over 50: what to know
The American Cancer Society has issued new prostate cancer screening guidance, recommending PSA blood tests every two years for men at average risk aged 50 to 69. The change matters because the society says stronger evidence now shows screening can save lives by detecting cancer earlier, though testing can also lead to anxiety and treatment for cancers that may never become dangerous.
Black men and men with a family history of prostate cancer are advised to begin annual testing at 45. A raised PSA result should be checked again after two weeks to three months; if it remains high, an MRI or biomarker tests can help inform whether to have a biopsy, which is needed for a definitive diagnosis. For low-risk cancers, active surveillance should be offered as the initial option; the article says more than 36,000 people in the US are expected to die from prostate cancer this year.
In short
- Average-risk men aged 50 to 69 are advised to have PSA tests every two years.
- Black men and those with a family history should start annual testing at 45.
- Persistent raised PSA results may lead to further tests and a biopsy.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Regular PSA screening for men aged 50 to 69 could find aggressive cancers earlier, when treatment may be more effective, and the American Cancer Society says evidence that screening can save lives has strengthened. Offering earlier, annual testing to Black men and those with a family history may also help address their higher risk, while repeat tests and further assessment can guide decisions before biopsy.
The case against
Screening can produce false alarms and anxiety, and may identify slow-growing cancers that would never have caused harm, leading to unnecessary biopsies or treatment and its side effects. Even with follow-up tests and active surveillance, men may reasonably prefer to avoid routine testing unless they judge the potential benefit worth these burdens.
Explained simply
Prostate cancer develops in the prostate, a small gland in the male reproductive system. It often grows slowly and may cause no problems, but some cancers spread and can be life-threatening.
The PSA test is a blood test that measures a substance made by the prostate. A high result does not prove that someone has cancer, and follow-up checks may be needed; a biopsy, in which a small tissue sample is examined, can confirm a diagnosis.
Screening can find cancer earlier, but it can also lead to worry and treatment for cancers that would not have caused harm. For some cancers judged to be low risk, doctors may monitor them over time before recommending treatment.